EC
RGEN icon

Elequin Capital’s Repligen RGEN Stock Holding History

Elequin Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53K Sell
13
-30
-70% -$4.19K ﹤0.01% 511
2025
Q4 		$7.05K Buy
+43
New +$6.74K ﹤0.01% 275
2025
Q1 		– Sell
-61
Closed -$8.78K – 589
2024
Q4 		$8.78K Buy
61
+26
+74% +$3.73K ﹤0.01% 361
2024
Q3 		$5.21K Buy
+35
New +$5.02K ﹤0.01% 288
2024
Q2 		– Sell
-101
Closed -$18.6K – 327
2024
Q1 		$18.6K Buy
+101
New +$19.2K ﹤0.01% 53
2023
Q4 		– Sell
-8
Closed -$1.27K – 470
2023
Q3 		$1.27K Sell
8
-145
-95% -$23.7K ﹤0.01% 322
2023
Q2 		$21.6K Buy
+153
New +$24.5K 0.01% 231
2023
Q1 		– Sell
-7
Closed -$1.19K – 495
2022
Q4 		$1.19K Buy
+7
New +$1.27K ﹤0.01% 593
2022
Q3 		– Sell
-18
Closed -$3K – 655
2022
Q2 		$3K Sell
18
-6
-25% -$949 ﹤0.01% 319
2022
Q1 		$5K Buy
24
+19
+380% +$3.61K ﹤0.01% 216
2021
Q4 		$1K Buy
+5
New +$1.35K ﹤0.01% 47

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Elequin Capital's RGEN Position: Q1 2026 in Review

Elequin Capital reduced its Repligen (RGEN) stake by 70% in Q1 2026, selling an estimated $4.19K and leaving 13 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #511.

Elequin Capital first reported a position in RGEN in Q4 2021 and has held it in 11 quarters since. The position peaked at $21.6K in Q2 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Elequin Capital held 13 shares of Repligen worth $1.53K as of Q1 2026.
  • Elequin Capital sold 30 Repligen shares in Q1 2026, an estimated $4.19K.
  • Repligen made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #511 holding.
  • Elequin Capital first reported a position in Repligen in Q4 2021 and has held it in 11 quarters since.
  • Elequin Capital's Repligen position peaked at $21.6K in Q2 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.